Imunon, Inc. (IMNN)
1.604
-0.04
(-2.20%)
USD |
NASDAQ |
Aug 24, 16:00
1.604
0.00 (0.00%)
After-Hours: 20:00
Imunon Total Assets (Quarterly) : 14.99M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.99M |
| March 31, 2026 | 8.019M |
| December 31, 2025 | 12.29M |
| September 30, 2025 | 8.988M |
| June 30, 2025 | 8.788M |
| March 31, 2025 | 6.862M |
| December 31, 2024 | 9.717M |
| September 30, 2024 | 14.39M |
| June 30, 2024 | 9.692M |
| March 31, 2024 | 14.32M |
| December 31, 2023 | 21.92M |
| September 30, 2023 | 24.65M |
| June 30, 2023 | 28.72M |
| March 31, 2023 | 42.11M |
| December 31, 2022 | 43.98M |
| September 30, 2022 | 60.53M |
| June 30, 2022 | 65.33M |
| March 31, 2022 | 64.34M |
| December 31, 2021 | 74.05M |
| September 30, 2021 | 79.47M |
| June 30, 2021 | 83.01M |
| March 31, 2021 | 73.04M |
| December 31, 2020 | 37.53M |
| September 30, 2020 | 37.27M |
| June 30, 2020 | 46.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 38.94M |
| December 31, 2019 | 38.28M |
| September 30, 2019 | 40.56M |
| June 30, 2019 | 43.59M |
| March 31, 2019 | 45.40M |
| December 31, 2018 | 46.86M |
| September 30, 2018 | 40.91M |
| June 30, 2018 | 49.51M |
| March 31, 2018 | 44.00M |
| December 31, 2017 | 47.51M |
| September 30, 2017 | 26.00M |
| June 30, 2017 | 29.66M |
| March 31, 2017 | 30.80M |
| December 31, 2016 | 30.85M |
| September 30, 2016 | 37.46M |
| June 30, 2016 | 43.51M |
| March 31, 2016 | 43.33M |
| December 31, 2015 | 49.03M |
| September 30, 2015 | 53.66M |
| June 30, 2015 | 60.41M |
| March 31, 2015 | 59.78M |
| December 31, 2014 | 66.69M |
| September 30, 2014 | 73.57M |
| June 30, 2014 | 79.58M |
| March 31, 2014 | 54.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 14.31M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.80M |
| Shareholders Equity (Quarterly) | 4.189M |
| Debt to Equity Ratio | 1.873 |
| Current Ratio | 1.819 |
| Net Debt Paydown Yield | -16.47% |